| Trial ID: | L4950 |
| Source ID: | NCT01302743
|
| Associated Drug: |
Group 1: Metformin
|
| Title: |
Cinnamon Bark, Water-Soluble Cinnamon Extract, and Metformin for Treatment of Type 2 DM.
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01302743/results
|
| Conditions: |
Diabetes
|
| Interventions: |
DRUG: Group 1: Metformin|DIETARY_SUPPLEMENT: Group 2: Cinnamon Bark|DIETARY_SUPPLEMENT: Group 3: Cinnulin PF
|
| Outcome Measures: |
Primary: Decrease in HbA1c, Subjects will have baseline blood levels to measure HbA1c. Subjects will then take either cinnamon bark powder, water-soluble cinnamon extract or metformin for 90 days then blood levels of HbA1c and lipid panel will be drawn again., 90 days|Decrease in LDL Cholesterol, Subjects will have baseline blood levels to measure LDL Cholesterol. Subjects will then take either cinnamon bark powder, water-soluble cinnamon extract or metformin for 90 days then blood levels of HbA1c and lipid panel will be drawn again., 90 days |
|
| Sponsor/Collaborators: |
Sponsor: Mike O'Callaghan Military Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
25
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-11
|
| Completion Date: |
2016-12
|
| Results First Posted: |
2017-03-28
|
| Last Update Posted: |
2017-06-26
|
| Locations: |
Mike O'Callaghan Federal Hospital, Nellis Air Force Base, Nevada, 89191, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01302743
|
